Archive
A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Roche inks $200M pact for Freenome's cancer screening blood test - Fierce Biotech
Roche inks $200M pact for Freenome's cancer screening blood test Fierce Biotech
Roche inks deal for rights to Freenome cancer tests outside US - MedTech Dive
Roche inks deal for rights to Freenome cancer tests outside US MedTech Dive
Roche Inks Another China ADC Pact With $1.5B Hansoh Bet - BioSpace
Roche Inks Another China ADC Pact With $1.5B Hansoh Bet BioSpace